Welcome Guest | Register / Login

Cancer Market Research Reports

Sort By
Title Published Price
Cancer Diagnostic Instrumentation 2019: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
By Venture Planning Group
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages...
Jul 2019 $ 1450
Tumor Infiltrating Lymphocytes: A New Frontier in Cancer Immunotherapy
By BCC Research
Report Includes:- An overview of Tumor Infiltrating Lymphocytes (TILs) for the treatment of metastatic cancer- Discussion of the development of TIL as a treatment option for melanoma and the possibilities to expand this therapy t...
Jul 2019 $ 995
Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025
By DPI Research
The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025. “Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025” presents an in-depth ...
Apr 2019 $ 1390
Cancer Genetics Inc (CGIX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its onc...
Mar 2019 $ 300
2019-2023 Cancer Diagnostic Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
By Venture Planning Group
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages...
Jan 2019 $ 950
Thyroid Cancer - Pipeline Insight, 2019
By Delve Insight
"Thyroid Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Thyroid Cancer development. The report provides detailed coverage of t...
Jan 2019 $ 1250
Thymus Cancer - Pipeline Insight, 2019
By Delve Insight
"Thymus Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Thymus Cancer development. The report provides detailed coverage of the...
Jan 2019 $ 1250
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2019
By Delve Insight
"Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Recurrent Head And Neck Cancer...
Jan 2019 $ 1250
Small Cell Lung Cancer - Pipeline Insight, 2019
By Delve Insight
"Small Cell Lung Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Small Cell Lung Cancer development. The report provides detail...
Jan 2019 $ 1250
Papillary Thyroid Cancer - Pipeline Insight, 2019
By Delve Insight
"Papillary Thyroid Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Papillary Thyroid Cancer development. The report provides de...
Jan 2019 $ 1250
Vulvar Cancer - Pipeline Insight, 2019
By Delve Insight
"Vulvar Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vulvar Cancer development. The report provides detailed coverage of the...
Jan 2019 $ 1250
Metastatic Liver Cancer - Pipeline Insight, 2019
By Delve Insight
"Metastatic Liver Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Metastatic Liver Cancer development. The report provides deta...
Jan 2019 $ 1250
Medullary Thyroid Cancer - Pipeline Insight, 2019
By Delve Insight
"Medullary Thyroid Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Medullary Thyroid Cancer development. The report provides de...
Jan 2019 $ 1250
Metastatic Prostate Cancer - Pipeline Insight, 2019
By Delve Insight
"Metastatic Prostate Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Metastatic Prostate Cancer development. The report provide...
Jan 2019 $ 1250
Nasopharyngeal Cancer - Pipeline Insight, 2019
By Delve Insight
"Nasopharyngeal Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nasopharyngeal Cancer development. The report provides detailed...
Jan 2019 $ 1250
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2019
By Delve Insight
"Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Non Muscle Invasive Bladder Cancer development. Th...
Jan 2019 $ 1250
Gallbladder Cancer - Pipeline Insight, 2019
By Delve Insight
"Gallbladder Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gallbladder Cancer development. The report provides detailed cover...
Jan 2019 $ 1250
Cancer Cachexia - Pipeline Insight, 2019
By Delve Insight
"Cancer Cachexia - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cancer Cachexia development. The report provides detailed coverage of...
Jan 2019 $ 1250
Anaplastic Thyroid Cancer - Pipeline Insight, 2019
By Delve Insight
"Anaplastic Thyroid Cancer - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anaplastic Thyroid Cancer development. The report provides ...
Jan 2019 $ 1250
North America Cancer Biomarker Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS The North American cancer biomarker market is all set to expand with a CAGR of 10.41% between the forecasted years of 2019-2027. The region holds the highest share in the global cancer biomarker market and also contribute the maxi...
Jan 2019 $ 1250
Europe Cancer Biomarker Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS The Europe cancer biomarker market is poised to grow at a CAGR of 10.83% for the years 2019-2027. Technological progress in research and developmental activities has progressed the growth of the cancer biomarker market in Europe....
Jan 2019 $ 1250
Asia Pacific Cancer Biomarker Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS The Asia-Pacific cancer biomarkers market is expected to rise with a CAGR of 13.23% for the years 2019-2027. Development in the healthcare facility in the region and growing government efforts to increase awareness are the major d...
Jan 2019 $ 1250
OHSU Knight Cancer Institute - Medical Equipment - Deals and Alliances Profile
By GlobalData
Summary OHSU Knight Cancer Institute (OHSU Knight), a subsidiary of Oregon Health & Science University is a provider of various therapies for cancer treatments. The institute conducts clinical trials to develop therapies for cancer treat...
Dec 2018 $ 250
Cancer Prevention Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Cancer Prevention Pharmaceuticals Inc (Cancer Prevention), a subsidiary of Zeria Pharmaceutical Co Ltd is a developer of novel therapeutics that offers agents diagnostics for the treatment of cancer. The company's pipeline produc...
Dec 2018 $ 250
OHSU Knight Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary OHSU Knight Cancer Institute (OHSU Knight), a subsidiary of Oregon Health & Science University is a provider of various therapies for cancer treatments. The institute conducts clinical trials to develop therapies for cancer treat...
Dec 2018 $ 250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy